Abu-Alfa 1/38 3/12/2016

ALI K. ABU-ALFA, M.D., F.A.S.N. American University of Beirut Faculty of Medicine Department of Internal Medicine Division of Nephrology and Hypertension AUB-Medical Center, Office E592 Offices/Assistants: Direct Office line +961-1-350000; Ext 5305 Executive Administrator +961-1-350000; Ext 5456 (Mrs Jamale Eid) Assistant (Nephrology) +961-1-350000; Ext 5353 Assistant (HRPP) +961-1-350000; Ext 5445 Fax: +961-1-370814 Mobile +961-71-423483 Global Voicemail +1-203-654-9779 Permanent US Address: 2480 Whitney Avenue, Unit 10 Hamden, CT 06518 USA Current Academic Appointments Professor of Medicine Department of Medicine American University of Beirut-Faculty of Medicine Oct 1, 2010 - current Adjunct Faculty Department of Internal Medicine Section of Nephrology Yale School of Medicine New Haven, CT, 06520, USA July 1, 2011 - current Current Regional and International Positions Member, Executive Committee, Kidney Disease Improving Global Outcomes (KDIGO), Jan 2016 - current

Founding President, Middle East Chapter, International Society for Peritoneal Dialysis

Dec 2014 - current Member, Board of Directors and Medical Advisory Board; Global Fibrosis Foundation 2010 - current Interim Secretary: 2014-current Current Administrative Responsibilities American University of Beirut and Faculty of Medicine Head, Division of Nephrology and Hypertension

Oct 2010 - current

Director, Renal Fellowship Program Oct 2010 - current

Abu-Alfa 2/38 3/12/2016

Organizer and Moderator Yale University - AUB Renal Pathology Videoconference Series University of North Carolina – AUB Glomerular Diseases Videoconference Series 2012 - current Director, Human Research Protection Program (AUB)

Jan 2011 - current Ex-Officio, Clinical Research Institute (AUB-Faculty of Medicine) Jul 2015 - current

Ex-Officio, Research Committee (AUB-Faculty of Medicine)

Jul 2015 - current Activity director, CME joint sponsorship program with Yale University Oct 2013 - current Current Responsibilities American University of Beirut Medical Center Chair, Organ Transplantation Committee Oct 2012 - current Chair, Pharmacy and Therapeutics Committee Jul 2012 - current Vice-Chair, Jan 2011 – Jun 2012 Member, Performance Improvement Committee July 2012 - current Member, Information Technology Steering Committee July 2011 - current Past Administrative Responsibilities American University of Beirut/ Medical Center / Faculty of Medicine Director, Clinical Research Institute (AUB-Faculty of Medicine) Jan 2011 - June 2015

Vice-Chair, Research Committee (AUB-Faculty of Medicine) Jan 2011 - June 2015 Lead Member/Member, Promotion Committee, Department of Internal Medicine 2010 - 2013 Vice-Chair, Institutional Review Board Oct 2010 - Dec 2010 Prior Administrative Responsibilities Yale School of Medicine, Section of Nephrology Director of Peritoneal Dialysis Program Associate Medical Director for Outpatient Dialysis Davita New Haven Dialysis Center

Abu-Alfa 3/38 3/12/2016

July 2000 - Sept 2010 Director of Clinical Trials in Nephrology July 2004 - Sept 2010 Coordinator, Yale Renal Biopsy - CPC Conference series July 2000 - Sept 2010 Coordinator, Invited Nephrology Lecture Series at Yale July 2000 - Sept 2010 Previous Academic Appointments: Yale University School of Medicine Associate Research Scientist/Attending Physician Section of Nephrology Department of Internal Medicine July 1993 - June 1995 Instructor in Medicine Section of Nephrology Department of Internal Medicine July 1995 - December 1995 Assistant Professor of Medicine Section of Nephrology Department of Internal Medicine January 1, 1995 - June 30, 2001 Associate Professor of Medicine Department of Internal Medicine Section of Nephrology Yale School of Medicine New Haven, CT, 06520, USA July 1, 2001- June 30, 2011 (last year on leave) Education College American University of Beirut Beirut, Lebanon October 1979 - August 1981 Degree awarded B.S. Mathematics, June 1985 Medical School American University of Beirut Beirut, Lebanon September 1981 - June 1985 Degree awarded M.D., June 1985 Residency American University of Beirut-Medical Center Department of Internal Medicine Internship July 1985 - June 1986 Northwestern University Medical School-McGaw Medical Center

Abu-Alfa 4/38 3/12/2016

Internal Medicine Residency July 1987 - June 1990 Fellowships Northwestern University Medical School Section of Nephrology Research Fellowship August 1986 - June 1987 Yale University School of Medicine Section of Nephrology Nephrology Fellowship July 1990 - June 1993 Special Programs Green Belt Six Sigma Program - General Electric, Healthcare division Yale-New Haven Hospital February 2002 - June 2004 Auditor Robert Wood Johnson Clinical Scholars Program in Clinical Epidemiology, Biostatistics and Clinical Research Study Design Yale University School of Medicine July 1995 - June 1996 Board and Societal Certifications Diplomat of the American Board of Int Med, Int Med, 1990, 2001 (eligible, recertification in progress) Diplomat of the American Board of Int Med, Nephrology, 1992, 2001, 2013 Specialist in Clinical Hypertension, American Society of Hypertension, 2005 - 2025 Medical Licensure State of Connecticut, USA 030742 Lebanese Order of Physicians 659/A Languages: English, Arabic and French Academic Honors - Dean's honor list, American University of Beirut, Faculty of Arts and Sciences; 1979 - 1981 - Dean's honor list, American University of Beirut, Faculty of Medicine; 1983 - 1985

- Department of Medicine Rambach award for best overall performance as a PGY1 trainee, Northwestern University Medical School; June 1988 - American Federation of Clinical Research, Trainee Research Award; April 1994 - Nominated for Humanism in Medicine Award, Yale School of Medicine, 2003 - Teacher of the Year Award, Department of Internal Medicine, American University of Beirut, 2011 - Alpha Omega Alpha, American University of Beirut Faculty of Medicine Chapter, 2011 - “Elected by his peers for inclusion” in Best Doctors in America®, 2003 - 2013

Trainees and Mentees (Research)

- Kassem Safa, MD: Resident, St Raphael hospital/Yale University; PD research, sarcoidosis and interferon case and literature review, 2009-2010.

- Armen Margaryan, MD: Research fellow in Nephrology, ISN/Yale University and Fellow in Nephrology, Yale University; CT-guided renal biopsy, anemia in hospitalized patients, EBD and ESRD case and literature review, 2003-2003 and 2008-2010

Abu-Alfa 5/38 3/12/2016

- Fidel Barrantes, MD: Fellow in Nephrology, Yale University: Late presentation of NSF, 2009-2010 - Janki Patel, MD, MPH: Resident, Bridgeport Hospital /Yale University; Screening for CKD prior to

GBCA use in MRI; 2008-2010 - Swarupa Eskapelli, MD: Resident, Norwalk Hospital /Yale University; Review and analysis of the

literature-reported NSF cases; 2007-2009 - Ian Wu, MD: Fellow in Nephrology, Yale University; PD catheter removal in peritonitis, 2008-2009 - Bushra Yusuf, MD: Fellow in Nephrology, Yale University; NSF and GBCA review and position

paper; 2007-2008 - Mira Rho, MD: Fellow in Nephrology, Yale University; Dialyzability of GBCA, 2007-2008

Trainees and Mentees (Special Training in Outpatient Hemodialysis and Peritoneal Dialysis)

- Ali Hariri, MD: Fellow in Nephrology, Yale University; Outpatient Hemodialysis Local, Regional, National and International Clinical, Educational and Academic Past Activities - Co-President, North American Chapter of the International Society for Peritoneal Dialysis July 2008 - June 2011 - Ex-Officio, North American Chapter of the International Society for Peritoneal Dialysis July 2011 - Sept 2012 - Member, Dialysis Advisory Group, American Society of Nephrology, Oct 2008 - Sept 2011

- 4th Peritoneal Dialysis conference of the North American Chapter of ISPD, Conference co-Chair, Yale University, New Haven, June 17 - 18, 2011

- PD for Acute Kidney Injury in Cambodia: A joint program with Americares, Baxter and Yale University: 2008 - 2011

- PD Academy (some activities accredited by the Royal College of Physicians-UK): Symposium Chair and/or Invited Speaker: Malaysia, Switzerland, Saudi Arabia, Cyprus, Turkey: 2007 – 2015 - PD Frontiers (Accredited by the Royal College of Physicians-UK): Symposium Chair/Speaker: Malaysia, Dubai, 2007 - 2011

--------------------------------------- - International Society of Nephrology - COMGAN: Ambassador Program Volunteer Faculty Member, 2009 - 2012 - Update in Nephrology - Kazan State Medical University, Kazan, Russia International Society of Nephrology - COMGAN sponsored conference

June 2-5, 2003 - Sabbatical leave at the American University of Beirut, Lebanon Review, analysis and updating Dialysis and CKD programs, April-June 2004 - Michael Smith Foundation, Grant Reviewer, Vancouver, Canada, 2003-2006

--------------------------------------- - American Society of Nephrology-Dialysis Advocacy Group, Member, 2008 - 2011 - American Society of Nephrology, Committee on informatics, Member, 2002 - 2004 - American Society of Nephrology, Peritoneal Dialysis, Abstracts Reviewer, 2000, 2005, 2013

Abu-Alfa 6/38 3/12/2016

-------------------------------------- - National Kidney Foundation and American College of Radiology, Joint Committee on NSF and safety of imaging in kidney patients. Lead author for joint position paper 2008 - 2010 - National Kidney Foundation, Clinical Research Committee, Member, 2005 - 2007

--------------------------------------- - National Kidney Foundation of Connecticut, Member, Medical Advisory Board, 2000 - 2009 - National Kidney Foundation of Connecticut, Research Committee, Chairman, 2000 - 2006 - National Kidney Foundation of Connecticut, Professional Education Committee, 2001 - 2006 - National Kidney Foundation of Connecticut, Research Committee, Member, 1995 - 2006 ---------------------------------------

- First Annual Scientific Symposium on Nephrogenic Systemic Fibrosis and Gadolinium Based

MR Contrast Agents. Co-Chair, Yale University, May 2007 - Second Annual Scientific Symposium on Nephrogenic Systemic Fibrosis and Gadolinium

Containing Contrast Agents. Symposium Chair, Yale University, May 2008 - Third Annual Scientific Symposium on Nephrogenic Systemic Fibrosis and Gadolinium

Based Contrast Agents. Symposium Chair, Yale University, May 2009 - Fourth Annual Scientific Symposium on Nephrogenic Systemic Fibrosis and Gadolinium

Based Contrast Agents. Symposium co-Chair, Yale University and New York Academy of Sciences, May 14-15, 2010

- Fifth Annual Scientific Symposium on Nephrogenic Systemic Fibrosis and Allied Fibrotic Disorders. Symposium co-Chair, Yale University, May 20-21, 2011

- Sixth Annual Scientific Yale Fibrosis Symposium. Symposium Clinical Program Director, Yale University, November 16-17, 2012

- Seventh Annual Scientific Yale Fibrosis Symposium. Symposium Clinical Program Director, Yale University, November 14-15, 2013

- Eigth Annual Scientific Yale Fibrosis Symposium. Symposium Clinical Program Director, Yale University, April 23-25, 2015

- International Symposia Program: “Crucial Issues and Latest Advances in the

Management of Early Renal Insufficiency and Chronic Kidney Disease" Organizer and Director, Yale University, April 2002 and September 2002

- Yale School of Medicine Progress Committee: Member, 2007 - 2010 - Physician Associate Program, Yale University, Thesis Review Committee, 1999 - 2008 - Physician Associate Program, Yale University, Thesis Advisor, 1999 - 2008 - Faculty participant in the Yale Medical Professions Outreach Program for Yale undergraduate students interested in a shadowing experience, 2003 - 2010

- Yale Medical Group-Board of Governors: Clinical Information Systems Committee: Member, 2009 - 2010 - Sunrise Informatics Leadership Committee, Yale-New Haven Hospital, Member, 2006 - 2010 - Pharmacy & Therapeutics Committee, Yale-New Haven Hospital, Member, 2006 - 2010 - Pharmacy & Therapeutics Sunrise Subcommittee, Yale-New Haven Hospital, Member, 2006 - 2010 - Contrast Committee, Yale-New Haven Hospital, Member, 2006 – 2010

Abu-Alfa 7/38 3/12/2016

Editorial Boards and Ad-Hoc reviewer activities

- Editorial Board Member: Peritoneal Dialysis International, 2011-current - Editorial Board Member (nephrology), eMedicine CME Case Presentations, 2008 - 2011 - Editorial Board Member, Clinical Nephrology, 2005 - 2009 - Editorial Board Member, The Scientific Journal, 2005 - 2011 - American Journal of Kidney Diseases (AJKD) - Journal of the American Society of Nephrology (JASN) - Clinical Journal of the American Society of Nephrology (CJASN) - Kidney International (KI) - Clinical Nephrology (CN) - Journal of Bone and Mineral Research (JMBR) - Peritoneal Dialysis International (PDI) - Medscape CME – Nephrology Emergency Room Series - American Journal of Medical Sciences - Lebanese Medical Journal - Hospital Physician - European Journal of Internal Medicine - New England Journal of Medicine - PLOS One

Membership in Professional Societies - American Society of Nephrology, Fellow, 2004 - current - American Society of Nephrology, Member, 1992 - current - International Society of Nephrology, Member, 1993 - current - European Renal Association-EDTA, Member, 2013 - current - International Society for Peritoneal Dialysis, Member, 2000 – current - American Society of Hypertension, Member, 2004 - current - National Kidney Foundation, Member, 1999 – 2012 - American College of Physicians, Fellow, 1997 - 2006 - American College of Physicians, Member, 1991 - 1997 - American College of Physicians, Associate Member, 1987 – 1991 - Connecticut Medical Society, Member, 2008 - 2011 Clinical Trials and Research Interests and Grants (past, present and planned)

- Nephrogenic Systemic Fibrosis and Gadolinium Based contrast agents

- Epidemiologic studies on NSF (Sub-investigator, multi-institutional, RADAR center project, funded, NIH grant # 2 R01 CA102713-03A2)

- Meeting support grant, 4th annual NSF symposium 2010: Yale University and New York

Academy of Sciences (PI and symposium co-chair, funded, NIH grant # 1R13DK088440-01)

- Review and analysis of reported NSF cases

- Position paper on NSF and GBCA: American College of Radiology and National Kidney Foundation collaborative effort (lead author, committee member and organizer)

- Screening for CKD at point-of-care: Protocol and data analysis at YNHH

- Renal-Endocrine joint approach to Metabolic Bone Disease-CKD - Darbepoetin use in hospitalized patients

Abu-Alfa 8/38 3/12/2016

- Peritoneal Dialysis Tolerance Study

Completed Clinical trial (number):

ACEi and erythropoietin use in ESRD patients: single center study (1) Sensipar in ESRD: Phase 3 and Phase 3B: multi-center registration trials (4) Aranesp use in CKD patients STARR: phase 3 and 4; multi-center trials (2) Icodextrin use in PD patients: Phase 3 trials; multi-center (2) Initiation of PD: Healthy Start study, clinical trial, multi-center (1)

Clinical Initiatives and Outcome-Quality Initiative Programs: Six Sigma Green Belt Training and projects at Yale-New Haven Hospital:

- Erythropoietin use in hospitalized patients (a six-sigma project). - Parenteral nutrition in hospitalized patients (a six-sigma project).

Development and implementation of a Comprehensive Chronic Kidney Disease management program at Yale in Dana 3 clinic. Initial component focusing on anemia management has been established. Other components are being implemented with focus on secondary hyperparathyroidism at the present time. (Joined efforts with nursing staff and administration in Dana3 outpatient clinic)

Institution of an anemia management protocol for hospitalized CKD patients in close collaboration with Yale New Haven Hospital pharmacy department and P&T committee. (Joined effort with the Pharmacy department at YNHH)

Active participation in CT-guided renal biopsy program with special interest in tracking outcomes and safety of performing this procedure in the outpatient setting.

Implementation of automatic estimated GFR (eGFR) reporting using MDRD equation for all adult outpatient creatinine values measured at YNHH chemistry clinical laboratory. (Joined effort with Laboratory Medicine-Yale New Haven Medical Center) Advising and consulting with dietetic services at YNHH for review and update of renal diets. Standardizing in-patient peritoneal dialysis care with protocol revisions, nursing staff education, implementing routine use of automated cycler PD and introduction of the new icodextrin solution into routine clinical use at YNHH. Development and implementation of policies for administration of Gadolinium-Based Contrast Agents (GBCA) in CKD/ESRD patients and management of the risk for NSF.

Medical Informatics Interests and Activities 1) Web Design Yale School of Medicine 1995 - 1996 Design, testing and launch of Yale Nephrology world wide web site. Role: Project leader

Abu-Alfa 9/38 3/12/2016

1995 - 2009 Maintenance and updating of Yale Nephrology web site. Role: Project leader 2002 - 2003 Redesign of Internal Medicine web site with focus on standardizing information

presentation and format, especially for training programs. Role: Advisor 2005 - 2006 Project to improve and revise the interface between Internal Medicine academic

web sites and the Yale Medical Group Role: Participant 2009 - 2011 International Society for Peritoneal Dialysis-North American Chapter Web Page design 2) Medical Informatics systems: Yale New Haven Hospital 2011 - current Informatics Steering Committee, American University of Beirut-Medical Center

Role: Member 2006 - 2010 Informatics Leadership Committee, Yale-New Haven Hospital

Role: Member 2006 - 2010 Order sets and electronic flowsheets implementation in Sunrise Renal and dialysis-related sets Role: Ad-hoc advisor and reviewer. 2003 - 2007 Project for automatic reporting of eGFR Role: Lead advisor 2006 - 2010 Design, review and implementation of ordering pathways for contrast

administration (MR and CT), incorporating safety checks and renal status evaluation.

Role: Contrast Committee Member and lead renal advisor Yale School of Medicine 2009 - 2010 Yale Medical Group-Clinical Information Systems Committee Role: Member American University of Beirut-Medical Center 2011 - current AUBMC – Information Technology Steering Committee Role: Member 3) Database Design and related initiatives Yale School of Medicine: Section of Nephrology

Abu-Alfa 10/38 3/12/2016

Desktop Platforms: 1995 - 1996 Design, testing and implementation of a relational database for all kidney

biopsies done in CT since 1992. Database was designed using an advanced relational database program (4D-ACI)

1995 - 2004 Maintenance, upgrading and backing-up of database, now containing more then

3500 records, each with more than 400 fields 1995 -1997 Design, testing and implementation of a relational database for a clinical trial in

dialysis with full automation including reminders for study procedures, flags (4D-ACI)

1995 - 2001 Design, testing and implementation of a relational database for dialysis patients

(4D-ACI). Information included demographics, essential clinical info, reminders for plan of care

1998 - 2004 Design, testing and implementation of a relational database for procedures

performed by renal fellows (4D-ACI). It features user-friendly interface for quick data entry with automatic reporting and generation of forms for certification and program accreditation. Project included training new fellows on its use

Handheld Platforms 2000 - 2011 Design, testing and implementation of a relational database for clinical billing

entries using Palm OS platform (HanDBase) with a counter desktop analysis and charting Excel programming.

2001 - 2007 Design, testing and implementation of a relational database for essential clinical

trial information and log of investigator activities using Palm OS platform (HanDBase).

4) Committees and Research 2002 - 2004 American Society of Nephrology, Informatics Committee Role: Member 2001 - 2005 Project to improve care using telematics in peritoneal dialysis Role: Principal Investigator

Abu-Alfa 11/38 3/12/2016

Bibliography Publications - Journals 1) Abu-Alfa, A.; Ivanovich, P.; Mujais, S.: Uremic Exocrine Pancreopathy. Nephron 1988, (42) 2: 94-100. 2) Vakil, N.; Abu-Alfa, A.; Mujais, S.: Gentamicin nephrotoxicity in extrahepatic cholestasis: Modulation by dietary calcium. Hepatology 1989, (9) 4: 519-24. 3) Abu-Alfa, A.; Mujais, S.: Uremic Pancreopathy: Impaired secretory function in vitro. American Journal of Kidney Diseases 1992, (20) 6: 585-588. 4) Biemesderfer, D.; Pizzonia, J.; Abu-Alfa, A.; Exner, M.; Reilly, R.; Igarashi, P. and Aronson, P.S.: NHE3: A Na+/H+ Exchanger Isoform of Renal Brush Border. American Journal of Physiology 1993, (34), F736-F742. 5) Thomson, R.B.; Igarashi, P.; Biemesderfer, D.; Kim, R., Abu-Alfa, A.; Soleimani, M. and Aronson, P.S.: Isolation and cDNA cloning of Ksp-cadherin, a novel kidney-specific member of the cadherin multigene family. Journal of Biological Chemistry 1995, (270), 17594 - 17601. 6) Cruz, D.; Perazella, M.; Abu-Alfa, A. and Mahnensmith, R.: Angiotensin converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence for erythropoietin resistance. American Journal of Kidney Diseases 1996, (28), 535-540. 7) Biemesderfer, D.; Rutherford, P.A.; Nagy, T; Pizzonia, J.; Abu-Alfa, A. and Aronson, P.S.:

Monoclonal antibodies for high resolution localization of NHE3 in adult and neonatal rat kidney. American Journal of Physiology 1997, (2 Pt 2), F289-F299.

8) Rutherford, P.A.; Pizzonia, J.H.; Abu-Alfa, A., Biemesderfer, D; Reilly, R. and Aronson, P.S.:

Sodium-Hydrogen Exchange isoform expression in blood cells: implications for studies in diabetes mellitus. Exp. Clin. Endocrinol. Diabetes 1997; (105 Suppl 2), 13-16.

9) Rutherford, P.A.; Pizzonia, J.H.; Biemesderfer, D; Abu-Alfa, A.; Reilly, R. and Aronson, P.S.: Expression of Sodium-Hydrogen Exchange isoforms NHE1 and NHE3 in kidney and blood cells of rabbit and rat. Experimental Nephrology 1997, (5), 490-7. 10) Cayco, A.; Abu-Alfa, A.; Perazella, M. and Mahnensmith, R.: Optimal venous pressure value for screening for dialysis access arterio-venous graft impairment. American Journal of Kidney Diseases 1998, 32(2):302-8. 11) Pizzonia, J.; Biemesderfer, D.; Abu-Alfa, A.; Wu, M.S.; Exner, M.; Isenring, P.; Igarashi, P. and Aronson, P.S.: Immunochemical characterization of Na+-H+ exchanger isoform NHE-4. Am. J. Physiol 1998, (4 pt 2), F510-517.

12) Abu-Alfa, A.; Cruz, D.; Mahnensmith, R.; Perazella, M.; Simon, D. and Bia, M.: ACE- inhibitors do not induce rHuEpo (Epogen) resistance in hemodialysis patients: a prospective, cross-over study. American Journal of Kidney Diseases. 2000, 35(6):1076-1082. 13) Crowley, S.; Cantwell, B.; Abu-Alfa, A. and Rigsby, M.: Prevalence of persistent asymptomatic

proteinuria in HIV-Infected outpatients and lack of correlation with viral load. Clinical Nephrology, 2001, 55 (1): 1-6.

Abu-Alfa 12/38 3/12/2016

14) Alappan, R; Cruz, D.; Abu-Alfa, A; Mahnensmith, R and Perazella, M.: Treatment of severe intradialytic hypotension with addition of high dialysate calcium concentration to midodrine and /or cool dialysate. American Journal of Kidney Diseases, 2001 (37): 294-299.

15) Hoeben H; Abu-Alfa A; Mahnensmith R; and Perazella MA: Hemodynamics in patients with

intradialytic hypotension treated with cool dialysate or midodrine. American Journal of Kidney Diseases 2002 (39):102-7.

16) Abu-Alfa A and Perazella MA: ACE inhibitors and Anemia in Chronic Kidney Disease: A

complex interaction. (Letter to the editor). American Journal of Kidney Diseases, 2002 (39), 896-7.

17) Cosgrove CJ, Abu-Alfa AK and Perazella MA. Observations on HIV-associated renal disease

in the era of highly active antiretroviral therapy. Am J Med Sci. 2002, (323):102-6.

18) Abu-Alfa, A.; Burkart, J.; Piraino, B.; Pulliam, J. and Mujais, S.: Approach to fluid management in peritoneal dialysis: A practical algorithm. Kidney International, 2002 (62), S8 -S16.

19) Abu-Alfa, A: The ADEMEX study: Expanding the boundaries of peritoneal dialysis adequacy

beyond small solute clearances. Dialysis and Transplantation, 2003 (32), 115-121 (Editorial review).

20) Abu-Alfa, A: CKD series: Evaluation and treatment of anemia in chronic kidney disease.

Hospital Physician, 2003 (39), 31-38.

21) Hoeben H, Abu-Alfa AK, Reilly RF, Aruny JE, Bouman K and Perazella MA.Vascular access surveillance: evaluation of combining dynamic venous pressure and vascular access blood flow measurements. Am J Nephro 2003, 23(6):403-8.

22) Brewster, U; Cimapi, MA.; Abu-Alfa, A. and Perazella, MA.: Addition of sertraline to other therapies to reduce dialysis-associated hypotension. Nephrology 2003, 8(6): 296-301.

23) Block, GA, Martin, KJ, de Francisco ALM, Turner SA, Avram MM, Suranyi MG, Hercz G,

Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier F, Braun J, McCary LC, Zani VJ, Olson KA, Drüeke TB and Goodman WG. The Calcimimetic Cinacalcet Hydrochloride (AMG 073) for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients. New England J. Med 2004, 350 (15): 1520-1529.

24) Finkelstein F, Healy H, Abu-Alfa, A, Ahmad A, Brown F, Gehr T, Nash K, Sorkin M and

Mujais S, on behalf of the Icodextrin High Transporter Trial Group. Superiority of Icodextrin Compared to 4.25% Dextrose for Peritoneal Ultrafiltration. J Am Soc Nephrol 2005, 16: 546-554.

25) Brewster UC, Ciampi MA, Abu-Alfa AK and Reilly RF. A long-term comparison of sevelamer

hydrochloride to calcium-containing phosphate binders. Nephrology 2006, 11(2):142-146.

26) Kuo, PH, Kanal, M, Abu-Alfa, AK and Cowper, SE: Gadolinium-based MR Contrast Agents and Nephrogenic Systemic Fibrosis. Radiology 2007, 242(3):647-9

Abu-Alfa 13/38 3/12/2016

27) Saab G and Abu-Alfa, AK: Are Patients with Moderate Renal Failure at Risk for Developing Nephrogenic Systemic Fibrosis? Radiology 2007; 244: 930

28) Saab G and Abu-Alfa, AK: Will Dialysis Prevent the Development of Nephrogenic Systemic

Fibrosis After Gadolinium-Based Contrast Administration? Am J Roentgenol 2007 Sep;189 (3):W169.

29) Abu-Alfa, AK: The Impact of NSF on the Care of Patients with Kidney Disease. Proceedings

of the First Annual Symposium on Nephrogenic Systemic Fibrosis and Gadolinium Based MR Contrast Agents. J Am Coll Radiol 2008; 5:45-52.

30) Saab G and Abu-Alfa, AK: Nephrogenic systemic fibrosis-Implications for nephrologists. Eur

J Radiol 2008; 66:208-12.

31) Abu-Alfa, AK, Sloan L, Charytan C, Sekkarie M, Scarlata D, Globe D and Audhya P. Darbepoetin alfa The association of darbepoetin alfa with hemoglobin and health-related quality of life in patients with chronic kidney disease not receiving dialysis. Curr Med Res Opin; 2008: 24:1091-100.

32) Chaiban JT, Kalache SM, Abu Alfa AK, Shabb NS and Salti IS. The association of Hashimoto

disease and Congo red negative amyloidosis. Am J Med Sci.2008: 336:293-6.

33) Huen S, Hall I, Topol J, Mahnensmith R, Brewster U and Abu-Alfa A: Successful Use of IP Daptomycin in the Treatment of VRE Peritonitis. Am J Kidney Dis. 2009; 54:538-541.

34) Kuo PH, Abu-Alfa A, Bucala R, Griffith J, Carlson K, Girardi M, Weinreb J and Cowper S:

MRI in the era of nephrogenic systemic fibrosis: Review, controversies and suggestions for risk reduction. Applied Radiology, 2009, ePUB April 09.

35) Vakil V, Sung JJ, Piecychna M, Crawford JR, Kuo P, Abu-Alfa AK, Cowper SE, Bucala R and

Gomer RH: A Gadolinium–containing Magnetic Resonance Image Contrast Agent Promotes Fibrocyte Differentiation. J Magn Reson Imaging. 2009; 30(6):1284-8

36) Weinreb JC and Abu-Alfa AK: Gadolinium-based contrast agents and nephrogenic systemic

fibrosis: why did it happen and what have we learned? J Magn Reson Imaging. 2009; 30(6):1236-9.

37) Abu-Alfa, AK and Younes, A: Tumor Lysis Syndrome and Acute Kidney Injury: Evaluation,

Prevention, and Management. Am J Kidney Dis 2010; 55(5 Suppl 3):S1-13.

38) Margaryan A, Perazella M, Mahnensmitth R and Abu-Alfa AK: Experience with Outpatient Computed Tomograhic-Guided Renal Biopsy. Clinical Nephrology 2010; 74(6):440-5.

39) Cuffy MC, Singh M, Formica R, Simmons E, Abu-Alfa AK, Carlson K, Girardi M, Cowper SE

and Kulkarni S. Renal transplantation for nephrogenic systemic fibrosis: a case report and review of the literature. Nephrol Dial Transplant 2011; 26(3):1099-1101.

40) Abu-Alfa, AK: Nephrogenic Systemic Fibrosis and Gadolinium-Based Contrast Agents. Adv

Chronic Kidney Dis 2011; 18(3):188-198.

Abu-Alfa 14/38 3/12/2016

41) Girardi, M, Kay, J, Dirk, E, LeBoit, P, Abu-Alfa, AK and Cowper, SE: Nephrogenic Systemic Fibrosis: Clinicopathological Definition and Work-up Recommendations. Journal of the American Academy of Dermatology 2011 Dec;65(6):1095-1106

42) Golper T, Saxena A, Piraino B, Teitelbaum I, Burkart J, Finkelstein F and Abu-Alfa AK.

Systematic Barriers to the Effective Delivery of Home Dialysis in the US. Am J Kidney Dis. 2011 Dec;58(6):879-85

43) Ang C, Abu-Alfa AK, Abdullah K, Lowery M, Tamraz S, Al Olayan A, Naghy M, Sibai H,

Farran H, Shamseddine A, Farraj W, O’Reilly E, Shah M and Abou-Alfa GK. Gastrointestinal Cancer Educational Case Series: Hepatocellular carcinoma following renal transplantation. Gastrointest Cancer Res. 2011 Sep;4(5-6):180-3

44) Sibai S, Ishak, RS, Halawi R, Otrock ZH, Salman S, Abu-Alfa AK and Kharfan-Dabaja M.

Non-uremic calcific arteriolopathy (calciphylaxis) in a case of relapsed/refractory Hodgkin lymphoma: a hitherto unreported association. J Clin Oncol. 2012 Mar 1;30(7):e88-90.

45) Edwards EJ, Usmani S, Raisch D, McKoy J, Samaras A, Belknap S, Trifilio, Hahr A, Bunta A,

Abu-Alfa A, Langman C, Rosen S and West D. Acute Kidney Injury and Bisphosphonate Use in Cancer: A Report From the Research on Adverse Drug Events and Reports (RADAR) Project. J Oncol Pract. 2013 Mar; 9(2):101-6.

46) Abu-Mrad R, Abu-Alfa AK and Ziyadeh F. Effects of weight reduction regimens and bariatric

surgery on chronic kidney disease in obese patients. Am J Physiol Renal Physiol. 2013 Sep 1;305(5):F613-7.

47) Nardone B, Saddleton, E, Laumann AE, Edwards BJ, Raisch DW, McKoy JM, , Belknap S,

Bull C, Haryani A, Cowper SE, Abu-Alfa, AK, Miller FH, Godinez-Puig V, Dharnidharka VR and West DP. Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report. Pediatr Radiol. 2014 Feb;44(2):173-80.

48) Edwards, E, .... , Abu-Alfa AK, West DP: NEPHROGENIC SYSTEMIC FIBROSIS:

Advancing Pharmacovigilance through Academic-Legal Collaboration: The Case of Gadolinium-based Contrast Agents and Nephrogenic Systemic Fibrosis - A Research on Adverse Drug events and Reports (RADAR) Report. Br J Radiol. 2014; 87(1042)

49) Hunter RW, Dominiczak AF, Alwakeel J, Staessen JA, Jennings GL, Abu-Alfa AK, Webb DJ,

and Dhaun N. Hypertensive Encephalopathy and Renal Failure in a Young Man. Hypertension. 2016 Jan;67(1):6-13

Publications - Chapters

1) Implications of the ADEMEX trial. Mujais, A, Vonesh E. and Abu-Alfa, AK.

Contrib Nephrol. Basel, Karger, 2003, vol 140, pp 131–141.

2) Nephrogenic Systemic Fibrosis. LaChance A, Abu-Alfa, AK and Cowper S. "Dermatological Manifestations of Kidney Disease” Textbook (submitted)

3) Solutions for Peritoneal Dialysis. Abu-Alfa, AK and Mujais S. Suki and Massry "Therapy of Renal Disease and Related Disorders” Textbook. (submitted)

Abu-Alfa 15/38 3/12/2016

4) Nephrogenic Systemic Fibrosis: What every nephrologist should know. Abu-Alfa, AK and Saab G. Cowper S "Nephrogenic Systemic Fibrosis” Textbook (in preparation)

Publications - Abstracts 1) Abu-Jawdeh, G.; Mujais, S.; Abu-Alfa, A.; LaPointe, M.; Istefan, N.: Characterization of uremic left ventricular hypertrophy. (American Society of Nephrology 1988) 2) Abu-Alfa, A.; Pizzonia, J.; Biemesderfer, D.; Reilly, R.; Igarashi, P. and Aronson, P.: Transient expression of rabbit NHE1 in deficient LAP1 cells by use of Vaccinia/T7 system. (American Society of Nephrology, 1992) 3) Pizzonia, J.; Abu-Alfa, A.; Igarashi, P. and Aronson, P.S.: Endogenous membrane transport systems

involved in regulation in intracellular pH in Sf9 cells. (American Society of Nephrology, 1992) 4) Abu-Alfa, A.; Biemesderfer, D.; Pizzonia, J.; Reilly, R.; Igarashi, P. and Aronson, P.: Glycosylation of Na+-H+ exchanger isoforms NHE-1 and NHE-3. (American Federation for Clinical Research, April 1994, p317A) 5) Erb, B.; Geller, D. and Abu-Alfa, A.: Vancomycin - induced acute interstitial nephritis: Report of two

cases. (American College of Physicians - CT Chapter Scientific Meeting, May 1997) 6) Ghadiri, G., Abu-Alfa, A. and Mahnensmith, R.: Bacteremia in patients on maintenance hemodialysis. (American Society of Nephrology, 1998) 7) Mahnensmith, R., Brickel, H., Camacho, C., Perazella, M., Cruz, D. and Abu-Alfa, A.: Declines in

serum albumin in hemodialysis patients are linked to co-morbidity burden, acute intercurrent illness and hospitalization. (American Society of Nephrology, 1998)

8) Mahnensmith, R., Mahnensmith, M.P., Perazella, M., Abu-Alfa, A., Cruz, D., Brickel, H and Nicholaou, S.: Clinical experience with intradialytic administration of Amphotericin B for treatment of severe fungal infections in hemodialysis patients. (American Society of Nephrology, 1999) 9) Abu-Alfa, A., Drozdowicz, B, Mayber, N. and Mujais, S.: Higher fill volumes improved clearances but had no effect on albumin losses in PD patients: Results from the Peritoneal Instilled Volume Tolerance (PIVOT) study. (American Society of Nephrology, October 2000) 10) Abu-Alfa, A., Drozdowicz, B, Mayber, N. and Mujais, S.: Effect of higher fill volumes on intra-

peritoneal pressures (IPP) and ultra-filtration (UF) in PD patients: Results from the Peritoneal Instilled Volume Tolerance (PIVOT) study. (American Society of Nephrology, 2000)

11) Hoeben, H, Perazella, M, Aruny, J, Reilly, R, Mahnensmith, R and Abu-Alfa, A: Basilic vein

transposition for vascular access: A viable choice?. (Annual Conference on Dialysis, February 2001)

12) Hoeben, H, Abu-Alfa, A, Aruny, J, Reilly, R, Mahnensmith, R and Perazella, M: Access blood flow is superior to venous pressure as a predictor of significant vascular access stenosis. (Annual Conference on Dialysis, February 2001)

13) Abu-Alfa, A., Mayber, N. and Mujais, S.: Changes in MTAC with fill volumes: Results from the

Peritoneal Instilled Volume Tolerance (PIVOT) study. (American Society of Nephrology, 2001)

Abu-Alfa 16/38 3/12/2016

14) Mayber, N., Abu-Alfa, A., Nash, K. and Mujais, S.: Monitoring of variability in ultrafiltration in APD by continuous data capture. (American Society of Nephrology, 2001)

15) Abu-Alfa, A., Mayber, N. and Mujais, S.: Timely Initiation of Dialysis: Impact on Quality of Life.

(Annual Conference on Dialysis, 2002)

16) Margaryan, A, Mahnensmith, R., Perazella, M. and Abu-Alfa, A.: Experience with CT guided outpatient kidney biopsy. (American Society of Nephrology, 2002)

17) Block GA, Martin, KJ, Turner, SA, Avram, MM, Hercz, G, Abu-Alfa, AK, Coyne, DW, Cohen, RM,

Moe, SM, McCary, LC, Olson, KA and Goodman, WG. Phase 3 Study Results Demonstrate Efficacy and Safety of the Calcimimetic Cinacalcet HCl in Hemodialysis Patients with Secondary Hyperparathyroidism (HPT). (American Society of Nephrology, 2003).

18) Mittman N, de Francisco ALM, Drueke T, Fadda GZ, Arruda JA, Abu-Alfa AK, Lien YH, Olson KA,

Turner SA and Shapiro WB. Phase 3 data Demonstrates Effective Control of Parathyroid Hormone (PTH) and Ca x P after Treatment with Cinacalcet HCl. (National Kidney Foundation-Spring meeting 2004).

19) Sprague S, Healy H, Abu-Alfa A, Ahmad S, Brown F, Finkelstein FO, Gehr T, Sorkin MI, Stallard R,

on behalf of the Icodextrin High Transporter Trial Group. Superiority of icodextrin-induced peritoneal ultrafiltration compared to 3.86% glucose in high/high-average transporters: a double-blind randomized study. (Euro PD meeting, Aug 2004).

20) Finkelstein FO, Healy H, Abu-Alfa A, Ahmad S, Brown F, Gehr T, Nash K, on behalf of the Icodextrin

High Transporter Trial Group. Superiority of icodextrin for peritoneal ultrafiltration compared to 4.25% dextrose in high/high-average transporters. (American Society of Nephrology, 2004).

21) Chertow G, Corpier C, Zeig S, Stegman M, Lynn R, Abu-Alfa AK, Mischel S, Faddem S, Tucker K,

Shapiro W, Sugihara J, LaBrecque J, Bradley C, Turner SA, Block GA. TARGET: Achieving NKF-K/DOQI™ Goals with cinacalcet HCl in Dialysis Patients with Secondary Hyperparathyroidism (HPT). (American Society of Nephrology, 2004).

22) Block GA, Coco M, Abu-Alfa AK, Bradley CR, LaBrecque JF, Turner SA and Corpier CL. Cinacalcet

HCl reduces parathyroid hormone levels in dialysis patients with severe secondary hyperparathyroidism (HPT). (National Kidney Foundation, Spring Clinical Meeting 2005).

23) Bushinsky DA, Avram MM, Abu-Alfa AK, Borah MF, Shapiro WB, Olson KA, Klassen PS, Turner SA

and Goodman WG. Characterization of the Effects of Cinacalcet HCl on Serum Calcium in Dialysis Patients with Secondary Hyperparathyroidism (HPT). (American Society of Nephrology, 2005).

24) Abu-Alfa AK, Hertel J, Locay H, Scarlata D, D Globe and Audhya P: The Effect of Every-other-week

(Q2W) Darbepoetin alfa on Hemoglobin (Hb) Levels and Health-related Quality of Life (HRQoL) in Older Chronic Kidney Disease (CKD) Patients Naïve to Recombinant Human Erythropoietin (rHuEPO). (Accepted, American Geriatric Society, 2006)

25) Abu-Alfa AK, Hertel J, Locay H, Scarlata D, D Globe and Audhya P: The Effect of Every-Other-Week

(Q2W) Aranesp® (darbepoetin alfa) on Hemoglobin (Hb) Response and Health-related Quality of Life (HRQOL) in Older Patients with Anemia Associated With Chronic Kidney Disease (CKD). (Accepted, American Society of Consultant Pharmacists, 2006)

26) Eskapelli S, Saab G, Bennett C and Abu-Alfa A: Detailed review of published NSF cases. (Poster

presentation, American Society of Nephrology, 2008)

Abu-Alfa 17/38 3/12/2016

27) Barrantes F, Carlson K, Girardi M, Cowper S and Abu-Alfa AK: Late presenting NSF, a new concern for exposed patients? (Third Annual Symposium on NSF and GBCA, Yale University, New Haven, CT, May 2009. Poster presentation)

28) Patel J, Lee K, Weinreb J and Abu-Alfa AK: Screening for Chronic Kidney Disease at the Point-of-

Care prior to GBCA Administration. (Third Annual Symposium on NSF and GBCA, Yale University, New Haven, CT, May 2009. Oral presentation)

29) LaChance A, High W, Abu-Alfa AK and Cowper S: Total body survey of gadolinium levels in an

autopsy case of nephrogenic systemic fibrosis. (Third Annual Symposium on NSF and GBCA, Yale University, New Haven, CT, May 2009. Oral presentation)

30) Xu M, Abu-Alfa AK, High W, Kuo P and Cowper S: Clinicopathological, microanalytical and

physiological corroboration of NSF disease activity using inductively coupled plasma mass spectrometry and FDG-PET/CT imaging. (Third Annual Symposium on NSF and GBCA, Yale University, New Haven, CT, May 2009. Poster presentation)

31) Patel J, Weinreb J and Abu-Alfa, AK: Title: Screening for CKD at Point-of-Care Prior to GBCA

(Gadolinium-Based Contrast Agent) Use. (Poster Presentation, American Society of Nephrology Annual Renal Week, 2009)

32) Bull C, Laumann A, Raisch D, Cowper S, Abu-Alfa A, Edwards B, Papariello N, Mckoy J, Miller F,

St.-Pierre S, Belknap S and West D: SUSTAINED REPORTING OF NEPHROGENIC SYSTEMIC FIBROSIS (NSF) TO FDA CONTINUES DESPITE REPORTS OF DECREASED CASES. (Fourth Annual Symposium on NSF and GBCA, New York, NY, May 2010. Oral presentation)

33) Bull C, Laumann A, Raisch D, Cowper S, Abu-Alfa A, Edwards B, Papariello N, Mckoy J, Miller F,

St.-Pierre S, Belknap S and West D: Pediatric Cases of Nephrogenic Systemic Fibrosis (NSF)-A RADAR Report. (Fourth Annual Symposium on NSF and GBCA, New York, NY, May 2010. Poster presentation)

34) Safa K, Mujais S and Abu-Alfa, AK: Effect of Fill Volume on Accelerated Peritoneal Equilibration

Examination Time (American Society of Nephrology, Poster Presentation, Denver, CO, Nov 2010)

35) Clinton M, Onsi-Daouk, L, Kamal N and Abu-Alfa, AK: Should refugees from countries at civil war be regarded as vulnerable populations? (Accepted, American Association for Human Research Protection Program AAHRPP, Annual Meeting, Chicago, May 2015)

Abu-Alfa 18/38 3/12/2016

Invited lectures, courses and workshops: (Local, national and international) Nephrogenic Systemic Fibrosis

Title: Imaging the Renal Patient: State of the Art Lecture Description: Annual Society Scientific Meeting Role: Speaker Host Institution: Lebanese Society of Nephrology and Hypertension Date: October 15, 2015 Location: Beirut, Lebanon Title: Nephrogenic Systemic Fibrosis Description: 8th Annual Scientific Yale Fibrosis Symposium Role: Director, Clinical Science Program Host Institution: Yale School of Medicine Date: April 24-25, 2015 Location: New Haven, CT Title: Imaging the Renal Patient Description: Lecture Role: Invited Speaker Host Institution: ApEx 2014, The Nephrology Board Review Course & Fluid

Electrolytes Workshop (with ISN) Date: May 2, 2014 Location: Mumbai, India Title: Nephrogenic Systemic Fibrosis Description: 7th Annual Scientific Yale Fibrosis Symposium Role: Director, Clinical Science Program Host Institution: Yale School of Medicine Date: November 14-15, 2013 Location: New Haven, CT Title: Nephrogenic Systemic Fibrosis Description: Imaging the Patient with Renal Impairment Role: Participant in Video-taped program Host Institution: Medscape CME Date: August 8, 2013 Location: New York, NY

Title: Nephrogenic Systemic Fibrosis Description: 6th Annual Scientific Yale Fibrosis Symposium Role: Director Clinical Program and Speaker, Moderator Host Institution: Yale School of Medicine Date: November 16-17, 2012 Location: New Haven, CT

Abu-Alfa 19/38 3/12/2016

Title: Nephrogenic Systemic Fibrosis Description: Imaging the Patient with Renal Impairment Role: Participant in Video-taped program Host Institution: Medscape CME Date: August 8, 2013 Location: New York, NY

Title: 14th Congress of the International Society of Peritoneal Dialysis Description: Symposium: What to do when the PD patient needs imaging with

GBCA? Role: Invited speaker Host Institution: ISPD Date: September 9, 2012 Location: Kuala Lumpur, Malaysia

Title: Sheffield 2nd International Workshop on experimental studies of

NSF Description: Epidemiology of NSF in the USA and regulatory changes for

GBCAs Role: Invited speaker Host Institution: University of Sheffield Date: June 15, 2012 Location: Sheffield, United Kingdom Title: Nephrogenic Systemic Fibrosis Description: Dermatology Grand Rounds; Radiology Grand Rounds Role: Invited Speaker Host Institution: American University of Beirut Dates: December 8, 2010, and February 23, 2011 Location: Beirut, Lebanon Title: Nephrogenic Systemic Fibrosis Description: Renal Grand Rounds Role: Invited Speaker Host Institution: Winthrop University Hospital Date: September 2010 Location: Mineola, NY Title: Nephrogenic Systemic Fibrosis Description: 4th Annual Scientific Symposium on NSF and GBCA Role: Co-Chair and Speaker Host Institution: Yale School of Medicine and New York Academy of Sciences Date: May 14-15th, 2010 Location: New York, NY Title: Nephrogenic Systemic Fibrosis Description: Renal Grand Rounds Role: Invited Speaker Host Institution: University of Alabama Date: March 2010 Location: Birmingham, AL

Abu-Alfa 20/38 3/12/2016

Title: Nephrogenic Systemic Fibrosis Description: Renal Research Seminar Series Role: Invited Speaker Host Institution: Boston University Medical Center Date: February 2010 Location: Boston, MA Title: Nephrogenic Systemic Fibrosis Description: 5th CONGRESS OF NEPHROLOGY IN INTERNET Role: Invited Faculty Host Institution: Uninet and the Nephrology Division of Hospital General Yagüe,

Burgos, Venezuela Date: December 2009 Title: Nephrogenic Systemic Fibrosis Description: FDA Advisory Committee on GBCA Role: Public Hearing Session-Approved Speaker Host Institution: FDA Date: December 8th, 2009 Location: Gaithersburg, MD Title: Nephrogenic Systemic Fibrosis Description: Renal Grand Rounds Role: Invited Speaker Host Institution: New York University Date: September 14th, 2009 Location: New York, NY Title: Nephrogenic Systemic Fibrosis Description: Lecture Role: Invited Speaker Host Institution: International Society for Peritoneal Dialysis North American Chapter Meeting Date: August 28h, 2009 Location: Vancouver, BC - Canada

Title: Nephrogenic Systemic Fibrosis Description: Donald Silverman Memorial Lecture Role: Invited Speaker Host Institution: Bridgeport Hospital Date: May 14th, 2009 Location: Bridgeport, CT Title: Nephrogenic Systemic Fibrosis Description: 3rd Annual Scientific Symposium on NSF and GBCA Role: Chair and Speaker Host Institution: Yale School of Medicine Date: May 9th, 2009 Location: New Haven, CT

Abu-Alfa 21/38 3/12/2016

Title: Nephrogenic Systemic Fibrosis Description: Symposium-ASN renal week Role: Invited Moderator Host Institution: American Society of Nephrology Date: November 8th, 2008 Location: Philadelphia, PA Title: Nephrogenic Systemic Fibrosis Description: Lecture – Florida Society of Nephrology Role: Invited Speaker Host Institution: Florida Society of Nephrology Date: September 12th, 2008 Location: Fort Lauderdale, FL Title: Nephrogenic Systemic Fibrosis Description: Lecture Role: Renal Grand Rounds Host Institution: Northwestern Feinberg Medical School Date: August 13th, 2008 Location: Chicago, IL Title: Nephrogenic Systemic Fibrosis Description: Renal Grand Rounds Role: Invited Speaker Host Institution: American University of Beirut Date: June 19, 2008 Location: Beirut, Lebanon Title: Nephrogenic Systemic Fibrosis Description: Renal Grand Rounds Role: Invited Speaker Host Institution: University of Kansas Date: May 30th, 2008 Location: Kansas City, KS

Title: Nephrogenic Systemic Fibrosis Description: Second Annual Scientific Symposium on NSF and GCCA Role: Chair and Speaker Host Institution: Yale School of Medicine Date: May 10th, 2008 Location: New Haven, CT

Title: Nephrogenic Systemic Fibrosis Description: Lecture Role: Invited Speaker Host Institution: American Nephrology Nursing Association Date: May 6th, 2008 Location: Connecticut

Abu-Alfa 22/38 3/12/2016

Title: Nephrogenic Systemic Fibrosis Description: Medical Grand Rounds Role: Invited Speaker Host Institution: University of Kentucky Date: May 2nd, 2008 Location: Lexington, KY Title: Nephrogenic Systemic Fibrosis Description: Medical Grand Rounds Role: Invited Speaker Host Institution: Stamford Hospital Date: April 23rd, 2008 Location: Stamford, CT

Title: Nephrogenic Systemic Fibrosis Description: Lecture – Annual Dialysis Conference Role: Invited Speaker Host Institution: University of Missouri-Columbia Date: March 2nd, 2008 Location: Orlando, FL Title: Nephrogenic Systemic Fibrosis Description: Lecture Role: Invited Speaker Host Institution: Saint Francis Hospital Medical Symposium Date: January 19th, 2008 Location: Columbus, GA

Title: Nephrogenic Systemic Fibrosis Description: Medical Grand Rounds Role: Invited Speaker Host Institution: Rochester General Hospital Date: January 17th, 2008 Location: Rochester, NY Title: Nephrogenic Systemic Fibrosis Description: Medical Grand Rounds Role: Invited Speaker Host Institution: Berkshire Medical Center Date: January 11th, 2008 Location: Pittsfield, MA

Title: Nephrogenic Systemic Fibrosis-Renal Perspective Description: Lecture – ISN Comgan Role: Invited Speaker Host Institution: International Society of Nephrology Date: December 9th, 2007 Location: Dubai, UAE

Abu-Alfa 23/38 3/12/2016

Title: Nephrogenic Systemic Fibrosis-Renal Perspective Description: Lecture – RSNA National meeting Role: Invited Speaker, Plenary Session Host Institution: Radiological Society of North America Date: November 30th, 2007 Location: Chicago, IL

Title: Nephrogenic Systemic Fibrosis Description: Lecture – Renal Grand Rounds Role: Invited Speaker Host Institution: University of Virginia Date: September 10, 2007 Location: Charlottesville, VA Title: Nephrogenic Systemic Fibrosis Description: Lecture – Renal Grand Rounds Role: Invited Speaker Host Institution: Waterbury Hospital-Yale University Date: August 10, 2007 Location: Waterbury. CT Title: Nephrogenic Systemic Fibrosis Description: First Annual Scientific Symposium on NSF and GCCA Role: Co-director and Speaker Host Institution: Yale School of Medicine Date: May 4th, 2007 Location: New Haven, CT Title: Nephrogenic Systemic Fibrosis Description: Lecture – Medical Grand Rounds Role: Invited Speaker Host Institution: Texas Tech University Health Sciences Center Date: April 18th, 2007 Location: El Paso, TX

Title: Nephrogenic Systemic Fibrosis Description: Hot News in Nephrology – NKF Clinical Meeting Role: Invited Speaker Host Institution: National Kidney Foundation Date: April 11, 2007 Location: Orlando, FL Title: Nephrogenic Systemic Fibrosis Description: Meeting Role: Invited participant-Visiting Professor Lecture Series Host Institution: Food and Drug Administration Date: February 1, 2007 Location: Silver Spring, MD

Abu-Alfa 24/38 3/12/2016

Peritoneal Dialysis

Title: Patient Selection for Peritoneal Dialysis Fluid Management in Peritoneal Dialysis

Description: Sultanate of Oman First PD day Role: Invited Speaker Host Institution: Royal Hospital-Muscat-Sultanate of Oman (endorsed by ISPD-Middle East Chapter) Date: March 12th, 2016 Location: Muscat, Sultanate of Oman Title: The Role of Peritoneal Dialysis in Cardio-Renal Syndrome Description: Annual Society Scientific Meeting Role: Speaker Host Institution: Lebanese Society of Nephrology and Hypertension Date: October 16, 2015 Location: Beirut, Lebanon Title: The First Few Weeks on Peritoneal Dialysis Description: International Conference Role: Invited speaker and program co-Chair Host Institution: 12th Congress of the Arab Society of Nephrology and Renal

Transplantation and 6th ISN - EMAN Update Course in Nephrology and ISPD-Middle East Chapter pre-course

Date: December 10, 2014 Location: Dubai, UAE Title: 32nd Annual Congress of the Egyptian Society of Nephrology and

Transplantation Description: The benefits of the new PD Solutions PD Workshop: Meet the Experts Role: Invited speaker and panelist Host Institution: Egyptian Society of Hypertension and Transplantation, ISN, ERA Date: March 5-6, 2014 Location: Alexandria, Egypt Title: 50th European Dialysis Transplant Association Congress Description: Satellite Symposium on PD Role: Invited speaker Host Institution: EDTA/ERA Date: May 18-21, 2013 Location: Istanbul, Turkey Title: 5th ISN Update Course in Nephrology Description: Symposium Role: Invited speaker: What is new in PD? Host Institution: EMAN Date: December 9-12, 2011 Location: Dubai, UAE

Abu-Alfa 25/38 3/12/2016

Title: 5th Update of Nephrology Description: Symposium Role: Invited speaker Host Institution: Lebanese Society of Nephrology and Hypertension, ISN Date: October 27-29, 2011 Location: Beirut, Lebanon

Title: 4th Annual PD meeting of the North American Chapter of the

International Society for Peritoneal Dialysis Description: Symposium Role: Co-Chair and speaker Host Institution: NAC-ISPD and Yale University Date: June 17-18, 2011 Location: New Haven, CT Title: Functional Assessment of the Peritoneal Membrane Description: Lecture Role: Invited Speaker Host Institution: American Society of Nephrology Date: November 21, 2010 Location: Denver, CO Title: PD Case discussion Description: Seminar and Lecture Role: Invited Speaker Host Institution: Winthrop University Hospital Date: September 24, 2010 Location: Mineola, NY

Title: PD Case discussion and Fluid Management Description: Seminar and Lecture Role: Invited Speaker Host Institution: Henry Ford Hospital Date: December 1st, 2009 Location: Detroit, MI Title: Challenges of the long term PD patient Description: Session Role: Invited Chair Host Institution: International Society for Peritoneal Dialysis North American Chapter Meeting Date: August 28h, 2009 Location: Vancouver, BC - Canada Title: PD Case discussion Description: Lecture Role: Invited Speaker Host Institution: University of Kentucky Date: May 1st, 2008 Location: Lexington, KY

Abu-Alfa 26/38 3/12/2016

Title: Removal of catheter PD in Peritonitis Description: Lecture – Annual Dialysis Conference Role: Invited Speaker Host Institution: University of Missouri-Columbia Date: March 2nd, 2008 Location: Orlando, FL

Title: New Solutions for Peritoneal Dialysis Description: Lecture – ISN Comgan Role: Invited Speaker Host Institution: International Society of Nephrology Date: December 9th, 2007 Location: Dubai, UAE

Title: PD for the late presenting patient Description: Symposium Role: Invited Speaker Host Institution: British Renal Society- Annual meeting Date: June 11th, 2007 Location: Birmingham, UK Title: Adequacy, ultrafiltration and economics in Peritoneal Dialysis Description: Renal Grand Rounds Role: Invited Speaker Host Institution: University of Massachusetts Date: April 6, 2006 Location: Worcester, MA

Title: New Insights into the Peritoneal Membrane Description: Free Communication Session Role: Co-Moderator Sponsoring Institution: American Society of Nephrology Date: November 12, 2005 Location: Philadelphia, PA Title: Outcomes on dialysis; is there a modality effect? Description: Renal Grand Rounds Role: Invited Speaker Host Institution: Rhode Island Hospital Date: March 10, 2006 Location: Providence, RI Title: Tolerance of Dialysate Variation –Changes in dialysate and level

of supporting evidence – Peritoneal Dialysis Methods Description: FDA Fluids for Dialysis Workshop Role: Invited Speaker Sponsoring Institution: Food and Drug Administration

Date: September 27, 2004 Location: Bethesda, MD

Abu-Alfa 27/38 3/12/2016

Title: Adequacy and Fluid Management in Peritoneal Dialysis Description: Renal Grand Rounds Role: Invited Speaker Host Institution: Northwestern University Medical School Date: March 16, 2005 Location: Chicago. IL Title: Ultrafiltration Management in Peritoneal Dialysis Description: Peritoneal Dialysis Summit Role: Invited Speaker Sponsoring Institution: Gambro Healthcare – Western Division Date: September 13, 2004 Location: Las Vegas, NV Title: Adequacy and outcome in Peritoneal Dialysis Description: Renal Grand Rounds Role: Invited Speaker Sponsoring Institution: Massachusetts General Hospital Date: November 13, 2003 Location: Boston, MA Title: Current Issues in Peritoneal Dialysis: An Update Description: Peritoneal Dialysis Summit Role: Invited Speaker Sponsoring Institution: Gambro Healthcare – Western Division Date: September 22, 2003 Location: Las Vegas, NV Title: A First Class Therapy: Trials and Myths in PD Description: Session at the Annual Dialysis Conference Role: Invited Speaker Sponsoring Institution: University of Missouri Date: March 2003 Location: Seattle, WA Title: Ultrafiltration Management in Peritoneal Dialysis Description: CME Conference on Peritoneal Dialysis Role: Invited Speaker Sponsoring Institution: Gambro Healthcare – North Eastern Division Dates: October and November 2002 Locations: Northern New Jersey and Springfield, MA Title: Icodextrin Use in Peritoneal Dialysis Description: Annual Meeting Role: Invited Speaker Sponsoring Institution: Gambro Healthcare – North Central Division Date: May 2002 Location: Bonita Springs, FL

Abu-Alfa 28/38 3/12/2016

Title: Automated Peritoneal Dialysis Description: Annual Meeting Role: Invited Speaker Sponsoring Institution: Encontro Paulista de Nefrologia Date: May 2001 Location: Aguas de Lindoia, Brazil Title: Automated Peritoneal Dialysis: Prescription and Use Description: Annual Meeting Role: Invited Speaker Sponsoring Institution: Mexican Society for Investigational Nephrology Date: November 1999 Location: Acapulco, Mexico

CKD-MBD

Title: Extraskeletal calcification in CKD: Role of Phosphate Binders Description: Master Course in Hypertension Role: Invited speaker Host Institution: Balamand University CME and ERA/EDTA Date: March 20, 2014 Location: Beirut, Lebanon Title: CKD-MBD Description: Lecture Role: Invited Speaker Sponsoring Organization: 5th Annual Meeting of the Lebanese Society for Osteoporosis and

Metabolic Bone Disorders (OSTEOS) Date: December 7, 2013 Location: Beirut, Lebanon Title: CKD-MBD Description: Lecture Role: Invited Speaker Sponsoring Organization: Meeting of the Guandong Society of Nephrology Date: November 23, 2013 Location: Guanzhou, China Title: Role of FGF23 in CKD Description: Lecture Role: Invited Speaker Sponsoring Organization: Lebanese Society of Nephrology and Hypertension, and Societe de Nephrologie (France) Date: October 3, 2013 Location: Beirut, Lebanon

Abu-Alfa 29/38 3/12/2016

Title: Extraskeletal calcification in CKD Description: Symposium Role: Invited speaker Host Institution: Lebanese Society of Nephrology and Hypertension and Societe de Nephrologie (France) Date: October 3, 2013 Location: Beirut, Lebanon

Title: Post-Graduate Course in Nephrology Description: - Vitamin D receptor Activators (VDRA): Is there a difference?

- CKD-MBD:Clinical Guidelines Role: Invited speaker Host Institution: Malaysian Society of Nephrology and ISN Dates: September 20-21, 2013 Location: Kuala Lumpur, Malaysia

Title: CKD-MBD: A Focus on Vascular Calcification Description: Symposium Role: Invited speaker Host Institution: Lebanese Society of Nephrology and Hypertension and ISN Date: October 18-20, 2012 Location: Beirut, Lebanon Title: CKD-MBD: Role of FGF23 Description: Lecture-Medical Grand Rounds Role: Invited Speaker Sponsoring Institution: American University of Beirut Date: January 25, 2011 Location: Beirut, Lebanon Title: Secondary Hyperparathyroidism in CKD Description: Lecture-Renal weekends Role: Invited Speaker Sponsoring Institution: American Society of Nephrology Date: March 2010 Location: New York, NY Title: Phosphorus, Vitamin D and Secondary Hyperparathyroidism:

What are the Links? Description: Medical Grand Rounds Role: Invited Speaker Sponsoring Institution: Beth Israel Medical Center Date: June 11, 2009 Location: Newark, NJ Title: Phosphorus management in CKD Description: Lecture - Update in the management of CKD 2008 Role: Speaker Sponsoring Institution: Long Island College Hospital Date: May 31, 2008 Location: New York, NY

Abu-Alfa 30/38 3/12/2016

Title: Mineral and Bone Disorders in CKD Description: Renal Grand Rounds Role: Speaker Sponsoring Institution: University of Kentucky Date: May 2, 2008 Location: Lexington, KY

Title: Mineral and Bone Disorders in CKD Description: Renal Grand Rounds Role: Speaker Sponsoring Institution: Rochester General Hospital Date: January 17th, 2008 Location: Rochester, NY Title: Mineral and Bone Disorders in CKD Description: Medical Grand Rounds Role: Invited Speaker Host Institution: Stamford Hospital Date: October 3rd, 2007 Location: Stamford, CT Title: Use of Cinacalcet HCl in Secondary Hyperparathyroidism Description: Renal Grand Rounds Role: Invited Speaker Host Institution: University of Virginia Date: September 10th, 2007 Location: Charlottesville, VA Title: The Importance of Achieving NKF-K/DOQI Secondary

hyperparathyroidism Goals: Impact on Clinical Outcomes Description: Annual Dialysis Conference Role: Invited Speaker Sponsoring Institution: University of Missouri Date: February 27, 2006 Location: San Francisco, CA Title: Secondary Hyperparathyroidism in CKD Stages 3 and 4 Description: Diabetes & Metabolism Grand Rounds Role: Speaker Role: Speaker Sponsoring Institution: Cornell and Memorial Sloan Kettering Cancer Center Date: November 2, 2005 Location: New York, NY Title: Outcomes in CKD and Secondary Hyperparathyroidism Description: National Kidney Foundation of Virginia - Educational Meeting Role: Keynote Speaker Sponsoring Institution: Virginia Commonwealth University/Mid-Atlantic Renal Coalition Dates: September 23/24, 2005 Location: Portsmouth, VA

Abu-Alfa 31/38 3/12/2016

Title: Secondary Hyperparathyroidism in CKD Description: Renal Grand Rounds Sponsoring Institution: Drexel University Date: September 13, 2005 Location: Philadelphia, PA Title: Use of Cinacalcet HCl in the treatment of Secondary

Hyperparathyroidism Description: PPP 8th Conference: An International Symposium on the Basic and

Clinical Aspects of PTH and PTHrP. Role: Invited Speaker Host Institution: Yale School of Medicine Date: July 15, 2005 Location: New Haven, CT

Description: Renal Grand Rounds Role: Invited Speaker Host Institution: Dartmouth School of Medicine Date: June 30, 2005 Location: Lebanon, NH Description: Renal Summit Role: Invited Speaker Host Institution: University of Connecticut Date: February 4, 2005 Location: Farmington, CT Description: Endocrinology Grand Rounds Role: Invited Speaker

Host Institution: American University of Beirut – Medical Center Date: May 2005

Description: Endocrinology Grand Rounds Role: Invited Speaker

Host Institution: Yale School of Medicine Date: December 2004

Description: YNHH - Pharmacy Seminar Series Role: Invited Speaker

Host Institution: Yale New Haven Hospital Date: October 2004 Location: New Haven, CT Title: Clinical Differences and Therapeutic Management of Secondary

Hyperparathyroidism In Dialysis Patients Description: Continuous Medical Education Series Role: Invited Speaker Sponsoring Institution: The Endocrine Society Date: October 2003 Location: Miami, FL

Abu-Alfa 32/38 3/12/2016

Hypertension and Cardiovascular Disease Title: University Diploma Program - Cardiovascular and Hypertension Description: Renal Impact of Hypertension: Detection, Management and

Effect on Outcomes Role: Invited Faculty speaker Host Institution: The Foundation – Medical Research Institutes and Lebanese

University Faculty of Medicine

Dates: January 30, 2016 Location: Beirut, Lebanon Title: Progess in Nephrology Summit Description: Renal Artery Interventions in Hypertension and CKD Role: Invited speaker Date: December 12, 2015 Location: Dubai, UAE Title: Hot Topics in Nephrology, Hypertension and Transplantation Description: Resistant Hypertension Role: Invited speaker Host Institution: Florence Nightingale Hospital

Date: January 23, 2015 Location: Istanbul, Turkey Title: Sixth ISN EMAN Update Course in Nephrology 2014 Description: Resistant Hypertension Role: Invited speaker Host Institution: International Society of Nephrology, EMAN-UAE, ASNRT

Date: December 11-13, 2014 Location: Dubai, UAE Title: Vth Middle East CardioPace Conference Description: My patient has a renal artery stenosis and well controlled BP

Renal artery stenosis: Is opening mandatory in every RH? Role: Invited speaker Host Institution: CardioSTIM, European Board for Accreditation in Cardiology

Dates: September 24-26, 2014 Location: Beirut, Lebanon Title: Joint Meeting ISH-ESH ATHENS 2014 Description: Overview of the New CKD Staging System for non-

Nephrologists Role: Invited speaker Host Institution: European Society of Hypertension

Date: June 15, 2014 Location: Athens, Greece

Abu-Alfa 33/38 3/12/2016

Title: The Middle East Cardio - Metabolic workshops Description: Management of Renal Artery Stenosis Role: Invited speaker Host Institution: The Foundation – Medical Research Institutes and International

Society of Vascular Health

Date: May 17, 2014 Location: Dubai, UAE

Title: Master Course in Hypertension Description: Outcomes of Renal Sympathetic Denervation Role: Invited speaker Host Institution: Balamand University CME and EDTA/ERA

Dates: March 21, 2014 Location: Beirut, Lebanon

Title: Lebanese Society of Cardiology Description: ESC Guidelines: Hypertension in Special Conditions Role: Invited speaker Host Institution: Lebanese Society of Cardiology/European Society of Cardiology

Dates: March 14, 2014 Location: Faraya, Lebanon Title: The Middle East Cardio - Metabolic workshops Description: Renal Sympathetic Denervation for Resistant Hypertension Role: Invited speaker Host Institution: The Foundation – Medical Research Institutes and International

Society of Vascular Health

Dates: March 13, 2014 Location: Beirut, Lebanon

Title: 2nd European-Middle East Forum on

“Managing cardiovascular risk Factors in Clinical Practice” Description: Resistant Hypertension: Interventional Strategies Role: Invited speaker Host Institution: Serono Symposia International Foundation (CME by EACCME)

Dates: December 6, 2013 Location: Istanbul, Turkey Title: The Middle East Cardio - Metabolic workshops Description: How to evaluate Kidney Abnormalities? Role: Invited speaker Host Institution: The Foundation – Medical Research Institutes and International

Society of Vascular Health

Dates: December 1, 2012 and April 26, 2013 Location: Istanbul, Turkey

Abu-Alfa 34/38 3/12/2016

Title: Master Course in Hypertension Description: BP targets in CKD and diabetic patients Role: Invited speaker Host Institution: Balamand University CME and ISN/ERA/ISH. Dates: March 22, 2013 Location: Beirut, Lebanon

Title: Iraqi Society of Nephrology Annual Meeting Description: The Kidney in Hypertension Role: Invited speaker Host Institution: Iraqi Society of Nephrology and ISN

Dates: Nov 23-24, 2012 Location: Istanbul, Turkey Title: Cardio-renal Syndrome: Nephrologist’s Perspective Description: Heart Failure Symposium Role: Invited speaker Host Institution: Lebanese Society of Cardiology Date: May 10-11, 2012 Location: Beirut, Lebanon Kidney Diseases and Complications Title: Anemia of CKD and ESRD: An Update Description: Lecture Role: Invited Speaker Host Institution: Jordanian Society of Nephrology and Transplantation Annual

Meeting Date: February 12, 2016 Location: Dead Sea, Jordan Title: Fluid Electrolytes Workshop Description: Lecture and workshops Role: Invited Speaker Host Institution: ApEx 2014, The Nephrology Board Review Course & Fluid

Electrolytes Workshop (with ISN) Date: May 1, 2014 Location: Mumbai, India Title: 5th ISN Update Course in Nephrology Description: Symposium: Tumor Lysis Syndrome and other Oncologic

Emergencies for the Nephrologist Role: Invited speaker Host Institution: EMAN Date: December 9-12, 2011 Location: Dubai, UAE

Abu-Alfa 35/38 3/12/2016

Title: Ten Topics in Rheumatology Description: Symposium : Lupus Nephritis-Clinico-Pathologic Conference Role: Invited speaker Host Institution: Lebanese Society of Rheumatology Date: October 7, 2011 Location: Beirut, Lebanon

Title: Tumor Lysis Syndrome Description: CME Programs and Grand Rounds Series Development Role: Chairman (nephrology) Host Organization: Quintiles Medical Education Date: 2008 - 2010 Title: Mini-symposium: hot topics in Nephrology Description: Evening CME lectures, 2 days Role: Invited Speaker Host Institution: Tawwam Hospital-Al-Ain Date: May 23 - 24, 2006 Location: Abu-Dhabi, UAE

Title: Chronic Kidney Disease: A new perspective Description: Medical Grand Rounds

Role: Speaker Sponsoring Institution: American University of Beirut – Medical Center

Date: June 2005 Location: Beirut – Lebanon Description: Symposium for Primary Care Providers Role: Invited Speaker Sponsoring Institution: Veterans Affairs Medical Center Date: June 2002 Location: West Haven, Connecticut

Description: Symposium for Primary Care Providers Role: Co-organizer and syllabus development Sponsoring Institution: National Kidney Foundation of Connecticut

and the Yale School of Medicine CME office Date: October 2001 Location: Southbury, Connecticut Description: Creation of dedicated web pages for primary care providers Role: Development and implementation Sponsoring Institution: National Kidney Foundation of Connecticut and Yale CME office Date: October 2001 Location: Southbury, Connecticut

Title: Hypertension: Monitoring and Intervention

Description: Annual Meeting Role: Invited Speaker

Sponsoring Institution: NAAMA and Henry Ford Health Systems Date: June 28, 2005 Location: Beirut, Lebanon

Abu-Alfa 36/38 3/12/2016

Title: Dysfunctional Hemodialysis Access Catheter Description: Case Study for internet CME series on use of fibrinolytics Role: Case preparation and literature review Sponsoring Organization: Medical Education Group LLC (MEG) / LyticMedicus.org Date: September 2004 Title: Update in Nephrology – Kazan (Russia) Nephrology Conference Description: A 3-day nephrology conference with lectures and workshops Role: Faculty member and material preparation Sponsoring Institutions: International Society of Nephrology – COMGAN and Yale University Date: June 2003 Location: Kazan, Tatarestan, Russia

Title: Approach to vascular access for hemodialysis

Description: Annual Meeting Role: Invited Speaker

Sponsoring Institution: Mexican Society of Nephrology Date: September 1998 Location: Mazatlan, Mexico

Title: Pre - Dialysis care: optimizing management Description: Medical Grand Rounds

Role: Invited Speaker Sponsoring Institution: American University of Beirut – Medical Center

Date: February 1998 Title: Prevention of uremic complications: Anemia, osteodystrophy and

acidosis Description: Pre- dialysis care Symposium

Role: Invited Speaker Sponsoring Institution: Baptist Healthcare System

Date: January 1998 Location: Birmingham, Alabama

Title: Introduction to Computers in Nephrology

Description: Post graduate education course Title: Practical Computing for Nephrologists

Description: Renal Physician Association workshop Role: Faculty member Sponsoring Institution: American Society of Nephrology Date: October 1997

Location: San Diego, CA

Abu-Alfa 37/38 3/12/2016

Human Research Protection and Clinical Research

Title: Clinical Research Symposium Description: Setting up regulatory and ethical review infrastructure for

clinical research Role: Invited Speaker Host Organizations: University of Jordan Date: May 1-2, 2015 Location: Amman, Jordan Title: Regulatory updates on Clinical Trial submission

from Ethics Committee perspective Description: Clinical Trials in MENA region and Turkey Role: Invited Speaker Host Organizations: Fleming Europe Date: March 17, 2015 Location: Istanbul, Turkey Title: Introduction to Clinical Research Description: Academic Regional Workshop and Conference Role: Invited Speaker and Advisor to trainees Host Organizations: Memorial Sloan Kettering Cancer Center, Hamad Medical

Foundation, Weill-Cornell (Qatar) and AUB Date: October 12-15, 2015 Location: Doha, Qatar Title: Ethical and Regulatory Considerations in Research Involving

Human Subjects Description: Academic Conference Role: Invited Speaker Host Organizations: Bezmialem University Date: June 25, 2014 Location: Istanbul, Turkey

Title: Ethics committees Q&A – what does it take to ensure an

efficient approval process? Description: 2nd Annual Meeting - Partnerships in Clinical Trials (PCT)

MENA and Turkey Role: Invited Speaker Host Organizations: PCT Date: June 25, 2014 Location: Istanbul, Turkey Title: Ethical and Regulatory Considerations in Research Involving

Human Subjects Description: Keynote speaker: Annual Research Day Role: Invited Speaker Host Organizations: Lebanese American University Date: March 1, 2014 Location: Byblos, Lebanon

Abu-Alfa 38/38 3/12/2016

Title: Raising the bar on ethical decision-making in global research Description: Lecture/Panel Discussion Role: Invited Speaker Host Organizations: Western IRB Knowledge Summit - Western IRB Date: October 4-5, 2012 Location: Seattle, USA Title: Workshop of Baseline Needs Assessment for Breast Cancer

Awareness and Management in the Middle East Description: Lecture Role: Invited Speaker Host Organizations: Susan G Komen Foundation for the Cure-MENA Date: January 20, 2012 Location: Sharm El-Sheikh, Egypt

Title: 3rd Annual SEHA Research Conference Description: Lecture Role: Invited Speaker Host Organizations: Ministry of Health Abu-Dhabi and Mafraq Hospital Date: December 14-15, 2011 Location: Abu-Dhabi, UAE Title: Current Controversies in Research Ethics: Research Integrity,

Research Ethics Committees and International Clinical Trials Description: CME Program (AUB-Cleveland Clinic Foundation) Role: Invited Speaker Host Organizations: Salim El-Hoss Bioethics and Professionalism Program at the

American University of Beirut; UNESCO Date: September 16 and 17, 2011 Location: Beirut, Lebanon